We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current TMCI market cap is 421.74M. The company's latest EPS is USD -0.8902 and P/E is -7.57.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 62.21M | 51.11M | 44.46M | 45.09M | 68.71M |
| Operating Income | -6.78M | -18.97M | -21.38M | -15.13M | -204k |
| Net Income | -6.28M | -18.68M | -21.21M | -15.36M | -501k |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 57.37M | 94.42M | 141.84M | 187.12M | 209.36M |
| Operating Income | 855k | -16.51M | -34.84M | -51.43M | -55.69M |
| Net Income | -4.31M | -20.75M | -42.82M | -49.53M | -55.74M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 251.91M | 242.73M | 226.08M | 212.92M | 217.09M |
| Total Liabilities | 113.97M | 116.34M | 113.94M | 108.02M | 104.2M |
| Total Equity | 137.94M | 126.39M | 112.14M | 104.91M | 112.89M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 41.81M | 140.82M | 159.02M | 251.91M | 217.09M |
| Total Liabilities | 41.03M | 47.75M | 98.5M | 113.97M | 104.2M |
| Total Equity | 776k | 93.07M | 60.53M | 137.94M | 112.89M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -34.58M | -7.22M | -21.12M | -32.96M | -37.17M |
| Investing | -81.3M | 3.76M | 26.19M | 31.95M | 35.38M |
| Financing | 109.38M | -185k | 126k | 134k | 160k |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -4.49M | -17.19M | -30.65M | -34.58M | -37.17M |
| Investing | -1.07M | -2.71M | -76.52M | -81.3M | 35.38M |
| Financing | 11.5M | 107.65M | 20.81M | 109.38M | 160k |
| Market Cap | 421.74M |
| Price to Earnings Ratio | -7.57 |
| Price to Sales Ratio | 2.02 |
| Price to Cash Ratio | 37.18 |
| Price to Book Ratio | 3.74 |
| Dividend Yield | - |
| Shares Outstanding | 62.62M |
| Average Volume (1 week) | 510.14k |
| Average Volume (1 Month) | 396.02k |
| 52 Week Change | -46.29% |
| 52 Week High | 12.65 |
| 52 Week Low | 3.92 |
| Spread (Intraday) | 1 (13.42%) |
| Company Name | Treace Medical Concepts Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.treace.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
